The Development and Use of Vaccine Adjuvants

Author： Edelman R.  

Publisher： Humana Press, Inc

ISSN： 1073-6085

Source： Molecular Biotechnology, Vol.21, Iss.2, 2002-06, pp. : 129-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virus-like particles as vaccine adjuvants

By Gilbert Sarah  

Molecular Biotechnology, Vol. 19, Iss. 2, 2001-10 ,pp. : 169-177

Humana Press, Inc

Access to resources Recommend Favorite

Vaccine adjuvants: preparation methods and research protocols edited by Derek O'Hagan, humana press

By VanCott T.C.   Jackson H.M.  

Trends in Biotechnology, Vol. 18, Iss. 12, 2000-12 ,pp. : 511-511

Elsevier

Access to resources Recommend Favorite

Development of a varicella virus vaccine stabilizer containing no animal-derived component

By Chun Bok-Hwan  

Biotechnology Letters, Vol. 26, Iss. 10, 2004-05 ,pp. : 807-812

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of hepatitis C virus protein epitopes for vaccine development

By Koshy R.   Inchauspe G.  

Trends in Biotechnology, Vol. 14, Iss. 10, 1996-10 ,pp. : 364-369

Elsevier

Access to resources Recommend Favorite

A New HPLC Immunoaffinity Assay for Intact Hepatitis A Virus: Applications in Vaccine Process Development

By Aboud R.  

Biotechnology Techniques, Vol. 12, Iss. 6, 1998-06 ,pp. : 439-443

Springer Publishing Company

Access to resources Recommend Favorite